CLINICAL_TRIALS
trial_result
· 2010-12-07
Clinical Trial Update: A Study Using Botulinum Toxin Type A as Headache Prophylaxis for Migraine Patients With Frequent Headaches [Phase 3]
Summary
Phase 3 study evaluating botulinum toxin type A as a preventive treatment for patients with frequent migraines; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allergan | Conditions: Migraine Disorders | Phase 3 | Status: COMPLETED | Results posted: 2010-12-07